Daily Bulletin

The Times Real Estate

.

US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

SYDNEY, Aug. 7, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has awarded Rare Pediatric Disease Designation (RPDD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of...

Read more: US FDA Grants Rare Pediatric Disease Designation (RPDD) to Paxalisib for DIPG-PR Newswire APAC

Business News

pay.com.au unlocks untapped value through Avios and British Airways partnership

British Airways joins a growing list of transfer partners including Cathay Pacific and Thai Airways, empowering SMEs with expanded redemption options and flexibility  AUSTRALIA, 29 April 2025 — p...

Daily Bulletin - avatar Daily Bulletin

Why Ignoring a Windshield Chip Could Cost You More in the Long Run

(Source) When a stone from the road jumps to your windshield, you hear the distinctive tap. You check the glass window through your reflection to discover one tiny chip that seems insignificant. A sm...

Daily Bulletin - avatar Daily Bulletin

Top Tips for Landing Your First Job in Law

Starting your legal career is an exciting milestone – one that comes with its fair share of challenges and opportunities. Whether you’re fresh out of law school or looking to secure your first offic...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals